Postpartum Hemorrhage and Tranexamic Acid (.5 Class A CE with .5 Pharm)

Monday, August 12

4:45 PM - 5:15 PM

Location: Regency Ballroom D, Ballroom Level, West Tower

Speaker(s)

Dawn Lewellen, MHS, CRNA

Staff CRNA
Parkland Hospital
Arlington, Texas
Gregory Collins, DNP, CRNA

Partner
Anesthetic Solutions, LLP
Amarillo, TX

Maternal patient safety bundles are now a part of many hospital guidelines. A postpartum hemorrhage (PPH) case study will be presented covering anesthetic management and the use of tranexamic acid (TXA) during PPH. Recent clinical trials on TXA and the patient safety bundle for obstetric hemorrhage will be outlined. Thromboelastography interpretation in PPH will support the use of TXA.

Learning Objectives:

Identify indications for tranexamic use in women with postpartum hemorrhage.
Describe the mechanism of action and possible side effects of tranexamic acid use.
Describe the patient safety bundle for obstetrical hemorrhage and how to implement the guidelines with your facility.